LAS VEGAS, Aug. 19 /PRNewswire-FirstCall/ -- Cord Blood America, Inc. (OTC Bulletin Board: CBAI) (http://www.cordblood-america.com/) said today that its co-founder and CEO, Matthew Schissler, reviewed the Company's progress in 2010, saying it is "on track" to accomplish all of its goals, in an interview with analyst Francis Gaskins.
The entire interview is available at: http://gaskinsco.com/cbai-8-18.mp3
"We will continue to be aggressive in 2010 in acquisitions and diversifying revenues and in organic growth," Mr. Schissler said. In the detailed interview, Cord Blood America's CEO explained the Company's accomplishments and strategy in Europe, its achievements in China and South America, and its operations at its headquarters in Las Vegas, including how the revenue stream already became diversified in the second quarter of 2010.
About Cord Blood America
Cord Blood America (BULLETIN BOARD: CBAI) is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. (BULLETIN BOARD: CBAI) , visit our website at http://www.corcell.com/. For investor information, visit http://www.cordblood-america.com/.
CONTACT: Paul Knopick E & E Communications 949/707-5365 pknopick@eandecommunications.com
Cord Blood America, Inc.
CONTACT: Paul Knopick of E & E Communications, +1-949-707-5365,
pknopick@eandecommunications.com, for Cord Blood America, Inc.
Web Site: http://www.cordblood-america.com/
